Navigation Links
Celebrity Golf Classic raises $553,443 for Seena Magowitz Foundation
Date:2/27/2012

PHOENIX, Ariz. Feb. 27, 2012 The 9th annual Seena Magowitz Celebrity Golf Classic raised $553,443 for pancreatic cancer research at the Translational Genomics Research Institute (TGen) through the Seena Magowitz Foundation.

These funds will go toward new international clinical trials run by TGen's Pancreatic Cancer Research Team.

This was the first time that major retailers, producers and suppliers in the mattress industry longtime supporters of pancreatic cancer research came together at the landmark Arizona Biltmore for the annual Seena Magowitz tournament.

More than 200 golfers took to the links Dec. 3, 2011, followed by an award luncheon, at which Roger E. Magowitz, President and co-founder of the Seena Magowitz Foundation, challenged everyone, the way he challenges himself.

"If not me, then who?" said Magowitz, a Scottsdale resident who for nearly a decade has championed research into finding a cure for pancreatic cancer, a disease that took the life of his mother, Seena, in 2001. "The 'who' is each one of you in this room," he said. "The 'who' is your business and your friends. The 'who' is an entire mattress industry united to fighting pancreatic cancer. I've never heard of any entire industry fighting a disease. We can beat this disease."

Magowitz, a long-time industry retailer, now is charitable advisor for Houston-based Mattress Firm, who has become a major sponsor.

Steve Stagner, President and CEO of Mattress Firm, a leading national bedding specialty retailer, served as Honorary Tournament Chairman: "This year's Seena Magowitz Classic provided us with a great opportunity to rededicate our commitment to putting an end to pancreatic cancer."

Michael Bassoff, President of the non-profit TGen Foundation, expressed his deep gratitude for the significant contributions made this past year by Roger Magowitz and Steve Stagner.

"In our fight against pancreatic cancer, there is no more powerful ally than Roger Magowitz, whose own commitment has initiated many incredible partnerships within the home furnishings industry," Bassoff said. "We also are extremely grateful to have merited the support of Steve Stagner and the Mattress Firm."

In March 2011, Mattress Firm announced that it named TGen its "charitable partner of choice," specifically funding TGen's pancreatic cancer research.

In May 2011, Mattress Firm kicked off their fundraising efforts for TGen's pancreatic cancer clinical trials.

In December 2011, pancreatic clinical trials began through TGen and other sites that are named for Seena Magowitz.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a Perfect 10, Great Business Opp for Celebrity Retreat
2. New source of classical techniques for blood-based studies in the laboratory mouse
3. Editor of Springer classic human genetics reference receives prize
4. Study pinpoints genetic variation that raises a risk linked to bisphosphonates
5. Crowdfunding science: Student raises cash online to follow a flying fox
6. Paternity of subordinates raises cooperative effort in cichlids
7. Fading ability to taste iron raises health concerns for people over age 50
8. Extreme weight gain raises risk for recurrence among breast cancer survivors
9. Missing sugar molecule raises diabetes risk in humans
10. FASEB praises President Obama for increasing funding for research in his FY 2012 budget
11. New UCLA study raises questions about genetic testing of newborns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  If only ... tumor had a mutation-conferring resistance to chemotherapy, thousands ... genomics research has focused on finding these mutations ... even from circulating tumor DNA in blood — ... oncology therapeutics. Unfortunately, however, detecting these ...
(Date:2/16/2017)... ... 2017 , ... Avomeen & MichBio will be hosting a BioMixer next week ... Analytical Services (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers are a casual, ... interact with peers, make new connections and talk bio biz. , Cost:, ...
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., ... groundbreaking therapies to treat severe neurological disorders, today ... treated with AGT-181, the company,s investigational therapy for ... known as mucopolysaccharidosis type I, or MPS I). ... proof-of-concept (POC) study, presented today at the 13 ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology: